Titterton Lewis H jr
SEC Form 4 insider trading activity
Titterton Lewis H jr has filed 9 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Oct 26, 2026.
On the most recent filing, Titterton Lewis H jr is listed as Director at Anixa Biosciences Inc. Inside the rolling window, Titterton Lewis H jr reported 6 open-market purchases totaling $241K in ANIX and no open-market sales. The largest disclosed transaction in the window is a purchase of 49,036 ANIX shares on Sep 23, 2026, worth $132K.
Companies traded
Other insiders at ANIX
Insider Buying
$241K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Nov 18, 2025 | PRKR | Purchase | $1.0M |
Frequently asked questions
How many SEC Form 4 filings has Titterton Lewis H jr made?
Titterton Lewis H jr has filed 9 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Titterton Lewis H jr trade?
Titterton Lewis H jr has filed SEC Form 4 disclosures for 1 company, including ANIX.
When was Titterton Lewis H jr's most recent SEC Form 4 filing?
Titterton Lewis H jr's most recent SEC Form 4 filing on Tracefour is dated Oct 26, 2026.
What is Titterton Lewis H jr's total buy and sell value in the current window?
Inside the rolling retention window, Titterton Lewis H jr bought $241K and sold $0 based on SEC Form 4 filings.
What was Titterton Lewis H jr's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 49,036 ANIX shares on 2026-09-23, worth $132K, per SEC Form 4 filings.